Novel treatment shows promise against rare cancer in kids

by Carla K. JohnsonThis December 1993 microscope photo provided by the National Cancer Institute shows a typical neuroblastoma with rosette formation. In a study published Wednesday, April 5, 2023, in

Oncology March 25,2024

Novel treatment shows promise against rare cancer in kids

by Carla K. JohnsonThis December 1993 microscope photo provided by the National Cancer Institute shows a typical neuroblastoma with rosette formation. In a study published Wednesday, April 5, 2023, in

Oncology March 25,2024

A novel malaria vaccine vector that targets the liver

by Kanazawa UniversityThe IVIS imaging results for the livers collected from mice on day 8 or day 224 post-administration of AAV-Luc showed that systemic administration of AAV8 induced ~24–43 tim

Hepatobiliary&Pancreas Surgery March 25,2024

A novel malaria vaccine vector that targets the liver

by Kanazawa UniversityThe IVIS imaging results for the livers collected from mice on day 8 or day 224 post-administration of AAV-Luc showed that systemic administration of AAV8 induced ~24–43 tim

Hepatobiliary&Pancreas Surgery March 25,2024

Novel form of immunotherapy could revolutionize cancer treatment

by Noelle Toumey Reetz,Georgia State UniversityFig. 1: Local RT eliminates late-stage MC38 tumors in Sirpα−/− mice but not WT mice. From: Intratumoral SIRPα-deficient macrophages activate tumor

Oncology March 25,2024

Novel form of immunotherapy could revolutionize cancer treatment

by Noelle Toumey Reetz,Georgia State UniversityFig. 1: Local RT eliminates late-stage MC38 tumors in Sirpα−/− mice but not WT mice. From: Intratumoral SIRPα-deficient macrophages activate tumor

Oncology March 25,2024

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Public Health & Prevention March 25,2024

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Public Health & Prevention March 25,2024

A new drug promises to lower risks of asthma attack

by Himanshu Kaul,The ConversationCredit: CC0 Public DomainArecent studyshows that a gamechanger drug called Fevipiprantpromises to lower patients' risks of suffering an ast

Immunology & Rheumatology March 25,2024

A new drug promises to lower risks of asthma attack

by Himanshu Kaul,The ConversationCredit: CC0 Public DomainArecent studyshows that a gamechanger drug called Fevipiprantpromises to lower patients' risks of suffering an ast

Immunology & Rheumatology March 25,2024

A novel immunotherapy proves effective in animal models of multiple sclerosis

by Thomas Jefferson UniversityThe purified oligodendrocyte extracellular vesicles under an electron microscope. Credit: G. Casella et al., Science Translational Medicine (2020)Multiple sclerosis

Neurology March 25,2024

A novel immunotherapy proves effective in animal models of multiple sclerosis

by Thomas Jefferson UniversityThe purified oligodendrocyte extracellular vesicles under an electron microscope. Credit: G. Casella et al., Science Translational Medicine (2020)Multiple sclerosis

Neurology March 25,2024

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Oncology March 25,2024

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Oncology March 25,2024

A possible cure for allergies

by Swiss Institute of Allergy and Asthma Research (SIAF)Scientists from Switzerland, Japan and the US discovered that mast cells are not only “bad guys” that initiate the allergic reaction, but also h

Immunology & Rheumatology March 25,2024

A possible cure for allergies

by Swiss Institute of Allergy and Asthma Research (SIAF)Scientists from Switzerland, Japan and the US discovered that mast cells are not only “bad guys” that initiate the allergic reaction, but also h

Immunology & Rheumatology March 25,2024

How an emerging drug class dampens harmful immune reactions

by Angelika Jacobs,University of BaselOverview of complement mechanisms and compstatin-based inhibitor development.aSimplified scheme of the complement cascade with major effector fu

Immunology & Rheumatology March 25,2024

How an emerging drug class dampens harmful immune reactions

by Angelika Jacobs,University of BaselOverview of complement mechanisms and compstatin-based inhibitor development.aSimplified scheme of the complement cascade with major effector fu

Immunology & Rheumatology March 25,2024

New type of treatment could reawaken immune response against prostate cancer

by Institute of Cancer ResearchA single prostate cancer cell. Credit:Anne Weston, Francis Crick Institute, CC BY-NCTargeting a molecule on the surface of immune cells could offer an excitin

Nephrology & Urology March 25,2024

New type of treatment could reawaken immune response against prostate cancer

by Institute of Cancer ResearchA single prostate cancer cell. Credit:Anne Weston, Francis Crick Institute, CC BY-NCTargeting a molecule on the surface of immune cells could offer an excitin

Nephrology & Urology March 25,2024